Catalent secures $700mm bridge loan commitment to support concurrent Cook Pharmica acquisition
- Contract Research, Toxicology Testing-CRO
- OTC, Consumer
- Controlled Release
- Drug Discovery Tools
- Synthesis Technologies, Production Processes
- Nonconvertible Debt
- Private Placement
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.